The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
tert-butyl N-[(4-tert-butylphenyl)methyl]-N-[4-(hydroxycarbamoyl)phenyl]carbamate ID: ALA4559559
PubChem CID: 155557777
Max Phase: Preclinical
Molecular Formula: C23H30N2O4
Molecular Weight: 398.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)OC(=O)N(Cc1ccc(C(C)(C)C)cc1)c1ccc(C(=O)NO)cc1
Standard InChI: InChI=1S/C23H30N2O4/c1-22(2,3)18-11-7-16(8-12-18)15-25(21(27)29-23(4,5)6)19-13-9-17(10-14-19)20(26)24-28/h7-14,28H,15H2,1-6H3,(H,24,26)
Standard InChI Key: SZBZYDVFLPQCJT-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 30 0 0 0 0 0 0 0 0999 V2000
28.4146 -28.3169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4134 -29.1405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1256 -29.5495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8394 -29.1401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8365 -28.3133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1238 -27.9039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1214 -27.0826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8320 -26.6719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4083 -26.6761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1254 -30.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8371 -30.7837 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8369 -31.6050 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.4134 -30.7834 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.8295 -25.8506 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.4038 -25.8589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1101 -25.4494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1060 -24.6330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3955 -24.2275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6877 -24.6443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6953 -25.4594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3899 -23.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0948 -22.9969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6795 -23.0065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3830 -22.5924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5404 -27.0793 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2474 -26.6694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9558 -27.0768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2460 -25.8523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9530 -26.2533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
7 9 1 0
3 10 1 0
10 11 1 0
11 12 1 0
10 13 2 0
8 14 2 0
9 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
21 22 1 0
21 23 1 0
21 24 1 0
8 25 1 0
25 26 1 0
26 27 1 0
26 28 1 0
26 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.50Molecular Weight (Monoisotopic): 398.2206AlogP: 5.04#Rotatable Bonds: 4Polar Surface Area: 78.87Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.19CX Basic pKa: ┄CX LogP: 4.87CX LogD: 4.86Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -1.19
References 1. Shouksmith AE, Gawel JM, Nawar N, Sina D, Raouf YS, Bukhari S, He L, Johns AE, Manaswiyoungkul P, Olaoye OO, Cabral AD, Sedighi A, de Araujo ED, Gunning PT.. (2020) Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia., 11 (1): [PMID:31938464 ] [10.1021/acsmedchemlett.9b00471 ]